Transparency Registry · applicant
Ischemaview, Inc.: 13 FDA AI clearances
Every 510(k) clearance held by Ischemaview, Inc. under the AI-associated product codes this registry tracks, from openFDA public records, refreshed weekly. Facts only; listing is not evaluation.
| Device | Decision date | Category |
|---|---|---|
| Rapid Aortic Measurements | 2025-09-23 | QIH |
| Rapid Obstructive Hydrocephalus, Rapid OH | 2025-09-04 | QAS |
| Rapid MLS | 2025-05-28 | QIH |
| Rapid Neuro3D | 2025-01-22 | QIH |
| Rapid (6.0) | 2024-01-16 | QIH |
| Rapid SDH | 2023-10-25 | QAS |
| Rapid Aneurysm Triage and Notification | 2023-07-27 | QFM |
| Rapid NCCT Stroke | 2023-03-02 | QAS |
| Rapid RV/LV | 2023-02-01 | QIH |
| Rapid ICH | 2022-09-12 | QAS |
| Rapid LVO | 2022-05-31 | QAS |
| Rapid PE Triage and Notification (PETN) | 2022-05-17 | QAS |
| Rapid LVO | 2020-07-09 | QAS |
Sources linked on each entry. Coverage note: this lists clearances under tracked AI-associated codes only — the company may hold other clearances outside them. Work for Ischemaview, Inc.? The disclosure rows on your entries update free on submission of public links — start here.
Link to this page. Many companies reference
their registry listing from press pages and footers — it is a neutral,
weekly-verified public record. Copy either snippet:
Text link:
Badge: